Zobrazeno 1 - 5
of 5
pro vyhledávání: '"S. G. Wicha"'
Autor:
A. Broeker, S. G. Wicha, C. Dorn, A. Kratzer, M. Schleibinger, F. Kees, A. Heininger, M. G. Kees, H. Häberle
Publikováno v:
Critical Care, Vol 22, Iss 1, Pp 1-7 (2018)
Abstract Background Tigecycline is a vital antibiotic treatment option for infections caused by multiresistant bacteria in the intensive care unit (ICU). Acute kidney injury (AKI) is a common complication in the ICU requiring continuous renal replace
Externí odkaz:
https://doaj.org/article/90db3dc321b04dcf913af22897381a27
Autor:
M G Vossen, S Pferschy, C Milacek, M Haidinger, Mario Karolyi, Zoltan Vass, Heinz Burgmann, Alexandra Maier-Salamon, S G Wicha, W Jäger, M Zeitlinger, T Stimpfl, T Wittek, F Thalhammer
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Elimination of a drug during renal replacement therapy is not only dependent on flow rates, molecular size and protein binding, but is often influenced by difficult to predict drug membrane interactions. In vitro models allow for extensiv
Externí odkaz:
https://doaj.org/article/f964f07fae8a4ef29aa69952c5d5f5c9
Autor:
W Kantasiripitak, S G WIcha, D Thomas, I Hoffman, M Ferrante, S Vermeire, K van Hoeve, E Dreesen
Publikováno v:
Journal of Crohn's and Colitis. 17:i659-i661
Background Adequate infliximab (IFX) concentrations during induction treatment are predictive for deep remission (corticosteroid-free clinical and endoscopic remission) at six months in children with Crohn’s disease (CD) and ulcerative colitis (UC)
Autor:
W Kantasiripitak, A Outtier, D Thomas, A Kensert, Z Wang, J Sabino, S G Wicha, S Vermeire, M Ferrante, E Dreesen
Publikováno v:
Journal of Crohn's and Colitis. 16:i350-i351
Background Underexposure to IFX is a common cause of loss of response in patients with inflammatory bowel disease (IBD). To ensure adequate – but not unnecessarily high – exposure, we aimed to identify a precise and unbiased approach for model-ba
Publikováno v:
Der Anaesthesist. 63(10)
Antibiotic agents are crucial pillars in intensive care medicine and must be used rationally and sensibly. In the case of critically ill patients optimal dosing with respect to pharmacokinetic and pharmacodynamic principles (PK/PD) can be vital. Prec